logo

WHO sees Zika link proven in weeks as India, US lead vaccine race

WHO sees Zika link proven in weeks as India, US lead vaccine race
A sharp increase in birth defects in Brazil has triggered a global health emergency over the mosquito-borne virus and spurred a race to develop a vaccine and better diagnostic tests.

"We have a few more weeks to be sure to demonstrate causality, but the link between Zika and Guillain-Barre is highly probable," Marie-Paule Kieny, WHO Assistant Director-General for Health Systems and Innovation, told a news briefing.

Kieny said U.S. government scientists and an Indian biotechnology company were currently frontrunners in vaccine development, although it would take at least 18 months to start large-scale clinical trials of candidate shots.

"Two vaccine candidates seem to be more advanced: a DNA vaccine from the U.S. National Institutes for Health and an inactivated product from Bharat Biotech in India," she said.

The NIH is working on a DNA-based vaccine that uses the same approach as one being developed for West Nile virus. India's Bharat said last week that its experimental vaccine would start pre-clinical trials in animals imminently. 

Overall, around 15 groups are working on Zika vaccines, including France's Sanofi (SASY.PA), as well as researchers in Brazil, who announced a new partnership with the University of Texas on Thursday. 

Agencies

Agencies

Our Contributor help bring you the latest article around you


Exclusive

View All

Latest News

View All
Share it
Top